Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.44 |
| ▸ | BTN3A1 | O00481 | 6/20 | 0.37 |
| ▸ | P2RY6 | Q15077 | 2/20 | 0.34 |
| ▸ | P2RY14 | Q15391 | 2/20 | 0.34 |
| ▸ | NT5E | P21589 | 1/20 | 0.34 |
| ▸ | SERPINA3 | P01011 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21511282 | 0.91 | CYP3A4 (0.47) | CYP3A4CYP2C9BTN3A1 | |
| SCHEMBL19987345 | 0.89 | CYP3A4 (0.43) | CYP3A4CYP2C9BTN3A1 | |
| SCHEMBL19987174 | 0.88 | CYP3A4 (0.45) | CYP3A4CYP2C9BTN3A1P2RY6P2RY14 | |
| SCHEMBL19987208 | 0.83 | CYP3A4 (0.49) | CYP3A4CYP2C9BTN3A1 | |
| SCHEMBL19987289 | 0.83 | CYP3A4 (0.49) | CYP3A4CYP2C9BTN3A1 | |
| SCHEMBL19987347 | 0.83 | CYP3A4 (0.44) | CYP3A4CYP2C9BTN3A1P2RY6P2RY14 | |
| SCHEMBL19987274 | 0.81 | CYP3A4 (0.49) | CYP3A4CYP2C9BTN3A1 | |
| SCHEMBL19987148 | 0.81 | CYP3A4 (0.48) | CYP3A4CYP2C9BTN3A1P2RY6P2RY14 | |
| SCHEMBL19987177 | 0.79 | CYP3A4 (0.45) | CYP3A4CYP2C9BTN3A1P2RY6P2RY14 | |
| SCHEMBL16998121 | 0.79 | CYP3A4 (0.43) | CYP3A4CYP2C9BTN3A1P2RY6P2RY14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2018049535-A1 | NUCLEOSIDE ANALOGUES AND METHODS OF USE THEREOF | LCB PHARMA INC. (CA) | 2018-03-22 | — | — | WO | disclosed |